Showing results (151-160 of 181) with videos related to
Sort By:
Pageof 19
Psychiatry|February 1, 1990
Evaluating the capacity to work of the mentally illH K Massel, R P Liberman, J Mintz, et al.The American Journal of Psychiatry|November 1, 1992
Technique for training schizophrenic patients in illness self-management: a controlled trialT A Eckman, W C Wirshing, S R Marder, et al.Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1995
Endogenous fluorescence of ocular malignant melanomasW Lohmann, W Wiegand, T R Stolwijk, et al.The American Journal of Psychiatry|November 30, 1999
Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependenceA P Ho, J W Tsuang, R P Liberman, et al.The American Journal of Psychiatry|May 1, 1994
Optimal drug and behavior therapy for treatment-refractory schizophrenic patientsR P Liberman, T Van Putten, B D Marshall, et al.British Journal of Clinical Pharmacology|November 1, 1988
Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflexG G Belz, J Essig, C H Kleinbloesem, et al.Archives of General Psychiatry|April 1, 1994
Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophreniaS R Marder, W C Wirshing, T Van Putten, et al.Journal of Clinical Psychopharmacology|April 1, 1989
Adverse effects of fenfluramine in treatment refractory schizophreniaB D Marshall, S M Glynn, K K Midha, et al.The American Journal of Psychiatry|December 1, 1996
Two-year outcome of social skills training and group psychotherapy for outpatients with schizophreniaS R Marder, W C Wirshing, J Mintz, et al.Clinical Pharmacology and Therapeutics|June 1, 1983
Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in anginaR A Morrison, U W Wiegand, E Jähnchen, et al.Pageof 19